Sputnik V vaccine trials on cancer patients are started in Russia

IMPORT Servisnyy

In Russia, they began to study the Sputnik V anti-coronavirus vaccine on cancer patients, the director of the Gamaleya Center Alexander Ginzburg said on the air of the Soloviev Live YouTube channel.

"Separate trials on cancer patients have already begun," said Ginzburg.

According to him, there are no oncological diseases that would be a contraindication to this vaccination. The only exceptions are cases when a patient is on chemotherapy, takes drugs that suppress cell proliferation.

"If a patient is on such drugs, vaccination will not harm them, but at the same time, the effect of vaccination will not be achieved," the head of the Gamaleya Center concluded.

Besides, the Sputnik V vaccine is contraindicated for people with severe allergic complications such as Quincke's edema so that after vaccination, they do not experience anaphylactic shock.

#sputnik v #trials #cancer

Join us - get more news faster on our social media:

Rubrics

Телефон

Office: +7(347) 250-05-07 Advertising office: +7(347) 250-11-11 Editors office: +7(347) 250-07-28 Cooperation: +7(347) 250-06-14

Эл. почта

inf@bashinform.ru

Адрес

450077, Ufa, Kirov street, 45

© 1992-2026 Bashinform News Agency JSC. Mass Media Registration Certificate No. TU 02-01609 dated September 25, 2017, issued by the Office of the Federal Service for Supervision of Communications, Information Technology and Mass Media for the Republic of Bashkortostan.

All information and content posted on the website www.bashinform.ru are protected by international and Russian copyright and related rights legislation. All reports by the Bashinform News Agency are intended for users over 18 years of age.

When reprinting or quoting, a reference to Bashinform News Agency is mandatory. For online publications and social media, a direct active hyperlink is required. Using the Bashinform News Agency logo for purposes not related to the agency when reprinting or quoting is permitted only with the written permission of JSC Bashinform News Agency.